Healthcare AI investors writing $25M+ checks

Investors whose typical check size falls in the $25M+ range for healthcare AI deals. Useful for sizing your round and identifying the right tier of partners.

Checks exceeding $25 million characterize extreme late-stage mega-rounds (Series C, D, and beyond) or massive private equity buyouts. In the AI and MedTech sectors, this capital supports profound infrastructural development, global scaling, and massive clinical deployments.
145 investors match

Within $25M+: top investment stages

Growth (140) Series C (55) Series B (44) Series A (28) Series D+ (22) Seed (14) Pre-Seed (4) Post-IPO (2)
KKR
PE T1
New York, United States
$25M+
KKR is one of the largest global investment firms, headquartered in New York and active across private equity, growth, infrastructure, real estate,…
Care Delivery / Tech-Enabled Services Pharma / Therapeutics
Korea Development Bank
PE T3
Seoul, South Korea
$25M+
Korea Development Bank is a state-owned policy bank headquartered in Seoul that provides large, anchor-style capital across the Korean economy, including biotechnology…
Biotech Pharma / Therapeutics
Korea Investment Corporation
PE T3
Seoul, South Korea
$25M+
Korea Investment Corporation is the sovereign wealth fund of South Korea, managing approximately $200 billion in assets across global public equities, fixed…
Biotech Pharma / Therapeutics
Lee Equity Partners
PE T3
New York, United States
$25M+
Lee Equity Partners is a New York middle-market private equity firm investing across healthcare services and financial services. The firm is oriented…
Care Delivery / Tech-Enabled Services
Life Sciences Innovative Manufacturing Fund
VC T3
London, United Kingdom
$25M+
The Life Sciences Innovative Manufacturing Fund is a major UK government intervention administered through the Department for Science, Innovation and Technology, providing…
Biotech Life Sciences Tools
Life Sciences Transformational R&D Investment Fund
VC T3
London, United Kingdom
$25M+
The Life Sciences Transformational R&D Investment Fund is a pilot UK sovereign capital program administered through the Department for Science, Innovation and…
Biotech Diagnostics
Linden Capital Partners
PE T3
Chicago, United States
$25M+
Linden Capital Partners is a Chicago-based private equity firm that invests exclusively in healthcare and life sciences, executing leveraged buyouts in middle-market…
Medical Devices / MedTech Pharma / Therapeutics
Longitude Capital
VC T3
Menlo Park, United States
$25M+
Longitude Capital is an established healthcare-dedicated venture firm investing across biotechnology and medical technology, with offices on both coasts and a long…
Biotech Care Delivery / Tech-Enabled Services
Loyal Valley Capital
PE T3
Shanghai, China
$25M+
Loyal Valley Capital is a Shanghai-based private equity firm that invests in growth and later-stage healthcare companies, with a focus on pharma…
Biotech Pharma / Therapeutics
LYFE Capital
VC T3
Shanghai, China
$25M+
LYFE Capital operates from Shanghai as a healthcare-focused venture firm with a growth-stage orientation, investing in biotech, medical devices, and digital health.…
Biotech Digital Health
Madison Dearborn Partners
PE T3
Chicago, United States
$25M+
Madison Dearborn Partners is a Chicago private equity firm with a long-running buyout practice that includes healthcare among its target sectors, alongside…
Care Delivery / Tech-Enabled Services
Martis Capital
PE T3
Washington, United States
$25M+
Martis Capital is a Washington, DC-based middle-market private equity firm investing exclusively in healthcare. The firm’s stated approach emphasizes collaboration with management…
Care Delivery / Tech-Enabled Services
Morgan Stanley Capital Partners
PE T3
New York, United States
$25M+
Morgan Stanley Capital Partners is the middle-market private equity arm of Morgan Stanley, investing from a New York base across multiple sectors…
Care Delivery / Tech-Enabled Services
Mubadala Investment Company
PE T3
New York, United States
$25M+
Mubadala Investment Company is the Abu Dhabi sovereign wealth investor, with a New York office among its global presence, deploying long-duration capital…
Life Sciences Tools Pharma / Therapeutics
Multiples Alternate Asset Management
PE T2
Mumbai, India
$25M+
Multiples Alternate Asset Management is a Mumbai-based mid-market private equity firm that drives growth-stage transactions across Indian healthcare and pharmaceuticals. Check sizes…
Care Delivery / Tech-Enabled Services Pharma / Therapeutics
AI Tool Finder
AI-powered search. Results may not be comprehensive.